Related Experiment Videos

[Analysis of autopsy data on patients who died at home of pneumonia]

E I Khristoliubova, L I Volkova

    Klinicheskaia Meditsina
    |August 29, 2001
    PubMed

    Insights

    Pneumonia is a common cause of death in autopsies. Primary pneumonia occurred more in males and was often bilateral and purulent, while secondary pneumonia frequently complicated cardiovascular diseases.

    Area of Science:

    • Pathology
    • Pulmonology
    • Epidemiology

    Context:

    • Autopsy data from 2675 individuals who died at home between 1995-1997.
    • Analysis of 298 pneumonia cases, differentiating between primary and secondary types.

    Purpose:

    • To characterize the epidemiological and pathological features of primary and secondary pneumonia in a deceased population.
    • To identify common characteristics and complications associated with each pneumonia type.

    Summary:

    • Primary pneumonia (61.0% of cases) predominantly affected males (85.2%), was frequently bilateral (52.2%), macrofocal (45.2%), and pyoserous (80.7%). Complications occurred in 27.5% of primary pneumonia cases, with purulent complications in 64.0%.
    • Secondary pneumonia (39.0% of cases) also showed a male predominance (69.8%) and commonly complicated cardiovascular diseases (69.0%). Small-focal (46.6%) and serous (44.8%) were characteristic of secondary pneumonia.

    Impact:

    • Provides insights into the distinct pathological patterns of primary versus secondary pneumonia.
    • Highlights the significant role of pneumonia, particularly secondary types, in mortality associated with cardiovascular disease.

    Related Concept Videos

    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pneumonia III: Complications and Assessment01:30

    Pneumonia III: Complications and Assessment

    Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Pneumonia II: Pathophysiology01:29

    Pneumonia II: Pathophysiology

    The pathophysiology of pneumonia involves the following steps:
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: